Clinical Trials Logo
  1. Home
  2. Postoperative Nausea
  3. NCT03387956
  4. Details
NCT03387956 Clinical Trial

Intrathecal Atropine to Prevent Postoperative Nausea and Vomiting

Postoperative Nausea Clinical Trial

Official title:
Intravenous Dexamethasone Combined With Intrathecal Atropine to Prevent Morphine-related Nausea and Vomiting After Cesarean Delivery: A Randomized Double-blinded Study

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03387956
Other study ID # IRB00009916
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 20, 2017
Est. completion date August 10, 2017

Study information
Verified date June 2018
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

optimal postoperative pain control with intrathecal morphine, with proper prevention of postoperative nausea and vomiting. Dexamethasone, and or atropine could offer some protection against nausea and vomiting.

Description:

One of the gold standards for analgesia following cesarean delivery is intrathecal morphine, which is not devoid of complications namely postoperative nausea and vomiting. We evaluated the antiemetic effect of intravenous dexamethasone combined with intrathecal atropine after cesarean delivery under spinal bupivacaine plus morphine anesthesia.

Recruitment information / eligibility
Status Completed
Enrollment 120
Est. completion date August 10, 2017
Est. primary completion date July 28, 2017
Accepts healthy volunteers No
Gender Female
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria:

- females

- 18-40 years of age

- elective cesarean delivery under bupivacaine spinal anesthesia

Exclusion Criteria:

- renal disease

- preeclampsia

- liver disease

- cardiac disease

- Coagulopathy

- chronic cough

- nausea

- vomiting

- patient refusal

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Intrathecal atropine
100ug intrathecal atropine will be injected with spinal anesthesia
• dexamethasone
intravenous 8 mg dexamethasone (2ml).

Locations
Country Name City State
Egypt Emad Zarief Kamel Said Assiut

Sponsors (1)
Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome
Type Measure Description Time frame Safety issue
Primary postoperative nausea Monitoring scale of nausea and vomiting 24 hours
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03639012 - Outcomes of Carbohydrate Loading Paediatric Patients Preoperatively for Tonsillectomy and Adenoidectomy N/A
Not yet recruiting NCT01389570 - Postoperative Nausea/Vomiting and Acupressure Phase 2
Completed NCT00830089 - Trial of a Transversus Abdominis Plane (TAP) Block in Laparoscopic Colorectal Surgery N/A
Terminated NCT05112575 - Evaluation of Patient Stress Level Caused by Radiological Investigations in Early Postoperative Phase After Craniotomy
Completed NCT04759079 - The Effects of Acupuncture Against Postoperative Nausea and Vomit After Laparoscopic Cholecystectomy N/A
Active, not recruiting NCT03712891 - Evaluation of Providing Coffee to Patients Postoperatively to Decrease Length of Stay in the PACU N/A
Completed NCT01834898 - Safety and Tolerability of Controlled-release Oxycodone on Postoperative Pain in Oncologic Head and Neck Surgery N/A
Completed NCT03631004 - Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients Phase 2/Phase 3
Active, not recruiting NCT05618236 - Sugammadex and Neostigmine in Pediatric Patients
Not yet recruiting NCT05632224 - Postoperative Nausea and Vomiting in Laparoscopic Abdominal Surgery Phase 4
Completed NCT01020903 - Aprepitant for Post-operative Nausea N/A
Completed NCT00793663 - Depth of Hypnosis and Postoperative Nausea and Vomiting During Xenon Anaesthesia Phase 4
Completed NCT03503292 - Pharmacogenomics and Post-Operative Nausea and Vomiting Phase 4
Completed NCT05841693 - Quality of Recovery in Parturients Consumed Preoperative Carbohydrate Fluid for Elective Cesarean Delivery Phase 4
Completed NCT04742660 - The Effect of Glycyrrhizin on the Occurrence of Postoperative Nausea and Vomiting N/A
Completed NCT03100669 - Implementing a Postoperative MIRP (Minimally Invasive Repair of Pectus) Program Via Tele-monitoring
Terminated NCT02765750 - Postoperative Outcomes After Positive Intraoperative Messages N/A
Terminated NCT01798316 - IV Acetaminophen for Postoperative Analgesia Phase 4
Completed NCT04718727 - Olanzapine for the Prevention of Postoperative Nausea and Vomiting Phase 1/Phase 2
Completed NCT01116713 - Effect of Dexamethasone in Postoperative Symptoms After Mastectomy for Breast Cancer Phase 3